Combination Chemotherapy, Monoclonal Antibody, and Natural Killer Cells in Treating Young Patients With Recurrent or Refractory Neuroblastoma
Clinical trial NCT01576692 · COMPLETED
Trial details
- NCT number
- NCT01576692
- Sponsor
- St. Jude Children's Research Hospital
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-04-01
- Primary completion
- 2014-10-01
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.